761 related articles for article (PubMed ID: 16892462)
1. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
2. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
Spencer K; Cowans NJ
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
[TBL] [Abstract][Full Text] [Related]
3. ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome.
Christiansen M; Spencer K; Laigaard J; Cowans NJ; Larsen SO; Wewer UM
Prenat Diagn; 2007 Jul; 27(7):611-5. PubMed ID: 17465398
[TBL] [Abstract][Full Text] [Related]
4. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
6. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
Wright D; Spencer K; Kagan K K; Tørring N; Petersen OB; Christou A; Kallikas J; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
[TBL] [Abstract][Full Text] [Related]
7. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
Pihl K; Larsen T; Krebs L; Christiansen M
Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
[TBL] [Abstract][Full Text] [Related]
8. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
9. [Second trimester screening for trisomy 21 using ADAM12-S as a maternal serum marker].
Jiang T; Lv L; Yang B; Sun YJ; Zhang XJ; Sun Y; Xu QJ; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):314-8. PubMed ID: 22678798
[TBL] [Abstract][Full Text] [Related]
10. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
11. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
12. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
14. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
[TBL] [Abstract][Full Text] [Related]
16. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of a disintegrin and metalloprotease 12 level in maternal serum during the first trimester with pregnancy outcome].
Qi H; Bian XM; Jiang YL; Liu SY; Guo Q
Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):401-4. PubMed ID: 19953936
[TBL] [Abstract][Full Text] [Related]
18. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
[TBL] [Abstract][Full Text] [Related]
19. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
[TBL] [Abstract][Full Text] [Related]
20. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
Spencer K; Bindra R; Cacho AM; Nicolaides KH
Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
